🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 17/04/2002 | 52,86 | 52,88 | 52,39 | 52,53 | +0,05% | 0,94% | 7.918.374 |
| 16/04/2002 | 52,43 | 52,74 | 52,05 | 52,50 | +0,90% | 1,31% | 7.640.863 |
| 15/04/2002 | 52,00 | 52,45 | 51,60 | 52,03 | +0,98% | 1,63% | 7.270.081 |
| 12/04/2002 | 50,18 | 51,72 | 49,62 | 51,53 | +3,55% | 4,18% | 11.284.235 |
| 11/04/2002 | 50,57 | 51,05 | 48,66 | 49,76 | -1,86% | 4,72% | 14.588.474 |
| 10/04/2002 | 51,29 | 51,33 | 50,48 | 50,71 | -0,84% | 1,66% | 11.391.865 |
| 09/04/2002 | 51,57 | 52,39 | 51,10 | 51,14 | -1,05% | 2,50% | 11.641.079 |
| 08/04/2002 | 52,56 | 52,96 | 51,53 | 51,68 | -1,97% | 2,72% | 9.804.774 |
| 05/04/2002 | 53,52 | 53,55 | 52,49 | 52,72 | -0,99% | 1,98% | 7.930.635 |
| 04/04/2002 | 53,58 | 53,67 | 52,72 | 53,24 | -2,60% | 1,78% | 14.351.731 |
| 03/04/2002 | 55,03 | 55,10 | 54,34 | 54,67 | -0,26% | 1,37% | 7.152.286 |
| 02/04/2002 | 54,96 | 55,11 | 54,20 | 54,81 | -0,28% | 1,65% | 7.415.962 |
| 01/04/2002 | 54,99 | 55,15 | 54,64 | 54,96 | +0,03% | 0,94% | 7.897.204 |
| 28/03/2002 | 54,78 | 55,06 | 54,63 | 54,94 | +0,30% | 0,78% | 6.613.404 |
| 27/03/2002 | 54,72 | 54,87 | 54,37 | 54,78 | +0,02% | 0,91% | 5.765.991 |
| 26/03/2002 | 54,96 | 55,34 | 54,53 | 54,77 | -0,19% | 1,48% | 5.974.543 |
| 25/03/2002 | 55,23 | 55,89 | 54,88 | 54,88 | -1,19% | 1,83% | 7.057.651 |
| 22/03/2002 | 55,06 | 56,18 | 55,06 | 55,53 | +0,26% | 2,04% | 5.629.646 |
| 21/03/2002 | 55,43 | 55,52 | 54,68 | 55,39 | -0,05% | 1,51% | 6.292.506 |
| 20/03/2002 | 55,74 | 56,25 | 55,08 | 55,42 | -0,58% | 2,11% | 10.064.049 |
| 19/03/2002 | 56,56 | 56,56 | 55,58 | 55,74 | -0,63% | 1,74% | 9.058.912 |
| 18/03/2002 | 56,55 | 56,97 | 55,83 | 56,10 | -1,61% | 2,01% | 13.601.258 |
| 15/03/2002 | 58,11 | 58,21 | 56,81 | 57,01 | -5,82% | 2,40% | 28.237.102 |
| 14/03/2002 | 60,93 | 61,36 | 60,43 | 60,53 | -1,44% | 1,52% | 4.040.040 |
| 13/03/2002 | 60,35 | 61,55 | 60,27 | 61,42 | +1,39% | 2,12% | 7.334.323 |
| 12/03/2002 | 59,66 | 60,64 | 59,17 | 60,58 | +1,20% | 2,46% | 4.151.023 |
| 11/03/2002 | 59,76 | 60,18 | 59,20 | 59,87 | +0,38% | 1,64% | 3.878.229 |
| 08/03/2002 | 60,28 | 60,58 | 59,35 | 59,64 | -1,06% | 2,04% | 4.676.386 |
| 07/03/2002 | 59,80 | 60,48 | 58,86 | 60,28 | +0,80% | 2,70% | 4.874.248 |
| 06/03/2002 | 59,06 | 60,12 | 59,02 | 59,80 | +1,39% | 1,87% | 5.101.978 |